ZYBT
Zhengye Biotechnology Holding Limited (NASDAQ)
Healthcare — Drug Manufacturers - Specialty & Generic
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Price History
Fundamentals
| Market Cap | $31.99M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-0.22 |
| Dividend Yield | - |
| Profit Margin | -59.97% |
| Revenue Growth | -40.90% |
| ROE | -25.17% |
| Debt/Equity | 24.48 |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 24.0 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $13.08 |
| 52-Week Low | $0.64 |
| 50-Day Avg | $0.86 |
| 200-Day Avg | $1.67 |
| Avg Volume | 90.2K |
| Volume | 550 |
Performance Analysis
NEUTRALZYBT presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:39 UTC
Back to Screener Export Report